Illuminating Parkinson's therapy with optogenetics

Controlling transplanted dopamine neurons with light helps define their mechanism of action.

[1]  B. Roth,et al.  DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. , 2015, Annual review of pharmacology and toxicology.

[2]  M. Nicolelis,et al.  Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled Receptors , 2009, Neuron.

[3]  K. Deisseroth,et al.  Millisecond-timescale, genetically targeted optical control of neural activity , 2005, Nature Neuroscience.

[4]  Karl Deisseroth,et al.  Optogenetics enables functional analysis of human embryonic stem cell–derived grafts in a Parkinson's disease model , 2015, Nature Biotechnology.

[5]  B. Roth,et al.  Chemogenetic tools to interrogate brain functions. , 2014, Annual review of neuroscience.

[6]  M. Umemiya,et al.  Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons. , 1997, Journal of neurophysiology.

[7]  B. Roth,et al.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand , 2007, Proceedings of the National Academy of Sciences.

[8]  Karl Deisseroth,et al.  Functional Control of Transplantable Human ESC‐Derived Neurons Via Optogenetic Targeting , 2010, Stem cells.

[9]  Linda Greensmith,et al.  Optical Control of Muscle Function by Transplantation of Stem Cell–Derived Motor Neurons in Mice , 2014, Science.

[10]  Yan Liu,et al.  Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network , 2011, Proceedings of the National Academy of Sciences.